Advances in Therapeutic Devices for Sleep Apnea (TechVision)

1.1 Scope of Research

1.2 Research Process Methodology

1.2 Research Methodology (continued)

1.3 Key Findings

2.1 Obstructive Sleep Apnea Constitutes over 80% of the Sleep Apnea Cases

2.2 High Marked Demand for a CPAP Alternative to Treat OSA

2.3 Adoption of CPAPs Hit due to Patient Non-Compliance

2.4 Over 80% of the CPAP Market Share is Owned by Two Companies

2.5 CPAPs Expected to Dominate due to Lack of Comparative Clinical Studies

2.6 ResMed Continues to Lead the CPAP Market with Their S9 Series

2.7 Philips Respironics offers One of the Most Recent Advancements in CPAPs

2.8 CPAP Non-compliance Leads Patients to Oral Device Therapy

2.9 Oral Device Therapy is Effective in Reducing Overall Apnea Hypopnea Index

2.10 Preference Towards Oral Device Therapy Increases as it Offers a Permanent Solution

2.11 ApniCure’s Invention works on Negative Oral Pressure

2.12 SomnoMed offers the largest range of Mandibular Advancement Devices

2.13 NPD Efforts Focus on Stimulation of the Hypoglossal Nerve

2.14 Device Miniaturization Expected to Boost the Neurostimulation Segment

2.15 Nyxoah focuses on Device Miniaturization and Reduced Surgery Time

2.16 Inspire Medical Systems Presents a Targeted Neurostimulation Therapy

2.17 ImThera Medical Aims to Provide Permanent Freedom from CPAP Masks

2.18 Non-invasive Offerings Expected to Cut Down Cost of Conventional Treatments

2.19 Provent Sleep Therapy Offers a Novel Approach to Treat Obstructive Sleep Apnea

2.20 Positional Therapy from Advanced Brain Monitoring Provides a New Approach to Treat OSA

2.21 Surgical Interventions Imperative for Severe OSA Cases

2.22 Assessment of Surgery in Comparison to CPAPs and OAs

3.1 Drivers and Challenges Shaping the Sleep Apnea Treatment Market

3.2 Advancements in Technology Leading to a Rise in Alternative Therapies for OSA Treatment

3.3 Poor Patient Compliance with Conventional Therapies is the Biggest Obstacle in the Sleep Apnea Market

4.1 Reimbursements Models Need to be More Favorable Globally to Promote Adoption

4.2 North American Market Remains the Top Consumer of Sleep Apnea Therapies

5.1 ResMed and Philips Respironics Continue to Rule the CPAP Market

5.2 Inspire Medical Systems Leads the Patent Filings in the Neurostimulation Segment

5.3 Oral Appliances Witness Continued Trends in Patent Applications

5.4 Surgery Options Witness a Slow Response in Patent Filings

5.5 USA Generates Maximum Interest in Novel Technologies, as Demonstrated by the Trend in Patent Applications

6.1 Adherence Tracking is Crucial to Improve Patient Compliance with Devices

6.2 Telemedicine to Help Improve the Quality of Sleep

7.1 Global Patents

7.1 Global Patents (continued)

7.1 Global Patents (continued)

7.1 Global Patents (continued)

7.2 Key Contacts

Legal Disclaimer

8.1 The Frost & Sullivan Story

8.2 Value Proposition: Future of Your Company & Career

8.3 Global Perspective

8.4 Industry Convergence

8.5 360º Research Perspective

8.6 Implementation Excellence

8.7 Our Blue Ocean Strategy